{
  "disease_allele_ingest_set": [
    {
      "condition_relations": [
        {
          "condition_relation_type": "induced_by",
          "conditions": [
            {
              "condition_chemical": "CHEBI:6432",
              "condition_class": "ZECO:0000111",
              "condition_statement": "chemical treatment:levamisole"
            }
          ]
        }
      ],
      "data_provider": "WB",
      "created_by": "WB:WBPerson324",
      "date_last_modified": "2021-09-01T00:00:00+00:00",
      "related_notes": [
        {
          "free_text": "summary statement",
          "note_type": "disease_summary",
          "internal": false
        }
      ],
      "evidence_codes": [
        "ECO:0000315",
        "ECO:0007013"
      ],
      "genetic_sex": "hermaphrodite",
      "mod_entity_id": "WBDOannot00001032",
      "modified_by": "WB:WBPerson324",
      "negated": false,
      "object": "DOID:11724",
      "predicate": "is_implicated_in",
      "single_reference": "PMID:24244862",
      "subject": "WB:WBVar00087752"
    }
  ],
  "disease_gene_ingest_set": [
    {
      "condition_relations": [
        {
          "condition_relation_type": "induced_by",
          "conditions": [
            {
              "condition_chemical": "CHEBI:34910",
              "condition_class": "ZECO:0000111",
              "condition_statement": "chemical treatment:pentylenetetrazole"
            }
          ]
        }
      ],
      "data_provider": "WB",
      "created_by": "WB:WBPerson324",
      "date_last_modified": "2021-08-24T00:00:00+00:00",
      "related_notes": [
        {
          "free_text": "summary statement",
          "note_type": "disease_summary",
          "internal": false
        }
      ],
      "disease_genetic_modifier": "WB:WBStrain00035193",
      "disease_genetic_modifier_relation": "ameliorated_by",
      "evidence_codes": [
        "ECO:0000315",
        "ECO:0007013"
      ],
      "genetic_sex": "hermaphrodite",
      "mod_entity_id": "WBDOannot00001014",
      "modified_by": "WB:WBPerson324",
      "negated": false,
      "object": "DOID:1826",
      "predicate": "is_implicated_in",
      "single_reference": "PMID:16996038",
      "subject": "WB:WBGene00011955"
    }
  ],
  "disease_agm_ingest_set": [
    {
      "created_by": "WB:WBPerson324",
      "data_provider": "WB",
      "date_last_modified": "2019-03-08T00:00:00+00:00",
      "disease_genetic_modifier": "WB:WBVar00250993",
      "disease_genetic_modifier_relation": "exacerbated_by",
      "evidence_codes": [
        "ECO:0000315",
        "ECO:0007013"
      ],
      "genetic_sex": "hermaphrodite",
      "mod_entity_id": "WBDOannot00000109",
      "modified_by": "WB:WBPerson324",
      "object": "DOID:10652",
      "predicate": "is_model_of",
      "single_reference": "PMID:22220943",
      "subject": "WB:WBStrain00005094"
    },
    {
      "condition_relations": [
        {
          "condition_relation_type": "ameliorated_by",
          "conditions": [
            {
              "condition_chemical": "CHEBI:30052",
              "condition_class": "ZECO:0000111",
              "condition_statement": "chemical treatment:Copper"
            },
            {
              "condition_chemical": "WB:WBMol:00004976",
              "condition_class": "ZECO:0000111",
              "condition_statement": "chemical treatment:Methazolamide"
            }
          ]
        }
      ],
      "created_by": "WB:WBPerson324",
      "data_provider": "WB",
      "date_last_modified": "2017-05-22T00:00:00+00:00",
      "related_notes": [
        {
          "free_text": "Mutations in human dystrophin are associated with the Duchenne and Becker types of muscular dystrophy, that affect skeletal muscles used for movement, and heart (cardiac) muscle; the genetic model for progressive myopathy in C. elegans is a mutant of the elegans dystrophin ortholog, dys-1, combined with a mutation in hlh-1, the MyoD ortholog, (dys-1(cx18);hlh-1(cc561ts), these animals display time-dependent muscle degeneration; a screen of approximately 1000 compounds on the dys-1(cx18),hlh-1(cc561) model, identified several substances that ameliorated the dystrophic phenotype, with the top hits being the sulfonamides, methazolamide (MTZ) and dichlorphenamide (DCPM), known inhibitors of carbonic anydrase (CA) enymes; knock-down of the elegans CA ortholog, cah-4, via RNAi interference, significantly reduced muscle degeneration in the dys-1(cx18),hlh-1(cc561) strain; further, the effects of MTZ and DCPM have been validated in the mdx mouse model for Duchenne muscular dystrophy (DMD).",
          "note_type": "disease_summary",
          "internal": false
        }
      ],
      "evidence_codes": [
        "ECO:0000315",
        "ECO:0007013"
      ],
      "genetic_sex": "hermaphrodite",
      "mod_entity_id": "WBDOannot00000110",
      "modified_by": "WB:WBPerson324",
      "object": "DOID:11723",
      "predicate": "is_model_of",
      "single_reference": "PMID:19648295",
      "subject": "WB:WBStrain00024340"
    }
  ]
}
